EMJ

EMJ #1 open access destination for HCPs & Pharma globally. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.

EMJ is the number one open access destination for HCPs and Pharma professionals globally. We do this across 18 therapy areas and the pharmaceutical sector via EMJ GOLD. We use industry-leading digital tools, to meet the challenges of time-poor medical professionals with a real passion to learn and in turn to elevate the quality of healthcare globally. Our content builds trust between healthcare professionals and Pharma, to help them continuously improve together. At the core of our content hub is a portfolio of peer reviewed, open access journals, which are complemented by alternative formats such as interviews, podcasts, webinars, and infographics. We have built our incredible team by recruiting on values. We stay true to these values in everything we do, as we remain steadfast in our goal to create Gold Medal Winners. For trusted partners who share our vision, we invite you to get in touch and join us on our journey.

Can we improve transplant outcomes with smarter tools and therapies?The EBMT 2026's congress explores this, from tacklin...
30/03/2026

Can we improve transplant outcomes with smarter tools and therapies?

The EBMT 2026's congress explores this, from tackling access gaps in gene therapy to enhancing recovery and predicting graft risks.

Dive into the highlights and discover more on EMJ Hematology: https://hubs.la/Q048Sz3K0

Have you seen our latest Flagship publication yet? Inside, uncover expert insights from our esteemed Editorial Board bel...
30/03/2026

Have you seen our latest Flagship publication yet? Inside, uncover expert insights from our esteemed Editorial Board below:

Prof. Markus Peck-Radosavljevic, Klinikum Klagenfurt am Wörthersee, Austria
Prof. László Vécsei, University of Szeged, Hungary
Prof. Abdullah Erdem Canda, Yildirim Beyazit University, Türkiye
Prof. Ahmad Awada, Jules Bordet Institute, Belgium

Read the journal free today: https://hubs.la/Q048R0tz0

Approximately half of patients with Type 2 diabetes have fatty pancreas disease, but why?Find out:
29/03/2026

Approximately half of patients with Type 2 diabetes have fatty pancreas disease, but why?

Find out:

Researchers have quantified the proportion of people with Type 2 diabetes who also have fatty pancreas disease. Read more.

What happens when AI and radiologists don’t agree?When AI findings conflict with clinical assessment, patient trust fall...
29/03/2026

What happens when AI and radiologists don’t agree?

When AI findings conflict with clinical assessment, patient trust falls and anxiety rises - unless clear explanations are provided.

Discover the study:

Learn how explaining discordant AI mammography results can reduce patient anxiety, preserve trust, and guide follow-up. Find out more.

Why does taste loss persist in long COVID?New research suggests molecular changes, not structural damage, may underlie o...
28/03/2026

Why does taste loss persist in long COVID?

New research suggests molecular changes, not structural damage, may underlie ongoing dysfunction.

Learn more:

Long COVID taste dysfunction linked to molecular changes in new study. Explore key findings and clinical impact. Read more.

Could the gut microbiome influence depression treatment response?A new study found faecal microbiota transplantation imp...
28/03/2026

Could the gut microbiome influence depression treatment response?

A new study found faecal microbiota transplantation improved outcomes when added to standard therapy.

Read more:

Faecal microbiota transplantation depression therapy showed improved outcomes and safety in a new trial. Learn more about this approach.

PCOS and depression are more closely linked than previously understood.New research points to a complex interplay of hor...
28/03/2026

PCOS and depression are more closely linked than previously understood.

New research points to a complex interplay of hormonal, metabolic, and psychosocial factors, with depression risk more than 2.5× higher in people with PCOS.

Uncover more of the findings:

Read more about the biological and psychosocial factors implicated in the relationship between PCOS and depression.

PCOS and depression are more closely linked than previously understood.New research points to a complex interplay of hor...
28/03/2026

PCOS and depression are more closely linked than previously understood.

New research points to a complex interplay of hormonal, metabolic, and psychosocial factors, with depression risk more than 2.5× higher in people with PCOS.

Uncover more of the findings: https://hubs.la/Q048fK5Z0

27/03/2026

Can GLP-1s improve survival in brain cancer?

New data reveals a surprising survival benefit for patients facing both Type 2 diabetes and brain metastases

Learn more: https://hubs.la/Q048BCXQ0

27/03/2026

On this week’s Hema Now, Karina Yazdanbakhsh, recipient of the Henry M. Stratton Medal for Basic Research at American Society of Hematology 2025, shares her journey into immunology and tackles one of the field’s biggest challenges: alloimmunisation.

From sickle cell disease to emerging technologies in personalised transfusion strategies, this episode offers critical insights into what’s changing and what still needs to improve.

🎧 Don’t miss this expert perspective, tune in: https://hubs.la/Q048BBcq0

Could virtual reality reshape how patients experience procedures?From VR improving patient experience to AI advancing pr...
26/03/2026

Could virtual reality reshape how patients experience procedures?

From VR improving patient experience to AI advancing prostate cancer diagnosis, the European Association of Urology 2026 congress highlights what’s next.

Read the full congress coverage by joining EMJ Urology today: https://hubs.la/Q048vM850

Address


Opening Hours

Monday 09:00 - 05:00
Tuesday 09:00 - 05:00
Wednesday 09:00 - 05:00
Thursday 09:00 - 05:00
Friday 09:00 - 05:00

Alerts

Be the first to know and let us send you an email when EMJ posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

EMJ is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in medicine. Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research papers from a variety of topics, alongside unique features and interviews.

The journal actively encourages members of the healthcare community to get involved, and there are plenty of opportunities to do so if you are interested. Featuring an online blog where both medical professionals, and members of the public can actively share their opinions about the most recent medical discoveries, debates, and controversies, EMJ welcomes contributions on relevant and topical subjects. For any members of the medical world who wish to act as editorial board members, peer-review papers, or even contribute articles to EMJ’s journals, then please do take a look at guidelines on the website: http://emjreviews.com/authors/, or get in contact to learn more: editor@emjreviews.com